(European Society of Human Reproduction and Embryology) The European Society of Human Reproduction and Embryology is setting the first ever standards in cross-border reproductive care. The safety of patients, gamete donors, surrogates and future children take center stage in...

PARSIPPANY, N.J. and BETHESDA, Md., April 20, 2011 /- The Sjogren's Syndrome Foundation (SSF), in partnership with Daiichi Sankyo Inc., today announced the launch of the Defy the Dry™ campaign, an educational initiative to ignite patient-physician dialogue about dryness symptoms....

April 20, 2011 4:36 am |
by Mass High Tech: The Journal of New England Technology |
Comments

Cambridge gene-therapy company bluebird bio has added Arch Venture Partners to its roster of backers for its latest round that brought in $30 million in financing, which the company describes in a press release as all part of its master plan to move its gene therapy platform quickly forward.

April 20, 2011 3:37 am |
by Mass High Tech: The Journal of New England Technology |
Comments

Cambridge gene-therapy company bluebird bio has added Arch Venture Partners to its roster of backers for its latest round that brought in $30 million in financing, which the company describes in a press release as all part of its master plan to move its gene therapy platform quickly forward.

IRVINE, Calif., April 20, 2011 /- Cardiogenesis Corporation (OTCQB: CGCP) announced that the company will release results for its first quarter ended March 31, 2011 on Wednesday, May 4, 2011. The company added that Paul J. McCormick, its Executive Chairman, and William R. Abbott,...

NEW YORK, April 20, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Levosimendan - Comprehensive patent search http://www.reportlinker.com/p0483048/Levosimendan---Comprehensive-patent-search.html Eliminate unnecessary risk with the...

(European College of Neuropsychopharmacology) The European College of Neuropsychopharmacology is pleased to announce Bertil Fredholm as the recipient of the 2011 ECNP Neuropsychopharmacology Award in Basic Science Research in recognition of his pioneering work on the brain...

VICTORIA, Australia, April 19, 2011 /- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) has executed a preliminary research collaboration agreement to jointly develop a new cancer profiling product with one of the world's leading pharmaceutical companies. Under the collaboration...